Articles Related to Thalassemia
Although common in the Mediterranean populations, β-thalassemia are present in various other parts of the world including south Asia and Africa. This study was aimed to re-evaluate the prevalence of β thalassemia, the specific underlying β globin gene mutations and their associated haplotypes in the Mauritanian population.
Thalassemia is one of the most common genetic disorders worldwide and presents a major public health problem and social challenge in parts where the frequency is high. The symptoms of the disorder are modulated by various environmental, racial and genetic factors. Therefore, dental specialists are obligated to have knowledge towards the nature of the disorder and its effect on dental health. Cooperation with a hematologist is recommended in every dental treatment.
Hemoglobin A2 (Hb A2) is a minor component of the hemoglobin present in normal adult red blood cells, accounting for 1.5-3.5% of the total hemoglobin in healthy individuals.
Spinal Cord Compression Due to Extramedullary Hematopoiesis in a 27-Year-Old Man with Beta Thalassemia Intermedia: A Case Report
Extramedullary hematopoiesis (EMH) occurs in approximately 15% of cases of thalassemia. Paraspinal mass of extramedullary hematopoiesis are a rare compensatory process in intermediate and severe thalassemia.
Sickle cell disease (SCD) is a hemoglobinopathy. Based on genotypes, it is classified into sickle cell thalassemia (SCTh) and sickle cell anemia (SCA).
Congenital Dyserythropoietic Anemia Type III and Primary Hemochromatosis; Coexistence of Mutations in KIF23 and HFE
Congenital dyserythropoietic anemia type III (CDA III) can be caused by mutation in KIF23. CDA III differs from CDA I and II in the sense that secondary hemochromatosis has not been reported. However, we have observed elevated serum ferritin in a CDA III family.
Extramedullary Hematopoiesis in a Non-Transfused Elderly Patient Diagnosed with Beta Thalassemia Minor
Extramedullary hematopoiesis (EMH) is a compensatory reaction caused by the presence of hematopoietic precursors outside the bone marrow, ineffective erythropoiesis and patients with chronic hemolytic anemia. The most frequent cause of EMH is thalassemia intermedia, that produces an increase in demand of the hematopoietic system caused by anemia and is not reduced by transfusion therapy.